Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Crown Bioscience Expands Partnership with NRCMM

publication date: Feb 12, 2015
Crown Bioscience, a US-China preclinical CRO, has extended its partnership with the National Resource Center for Mutant Mice (NRCMM) to build experimental immune-oncology mouse models along with models for diabetes and inflammation.  NRCMM was established by the US National Institute of Health and has a China commercial branch, the Nanjing Biotech Innovation Corporation. Crown Bioscience is headquartered in California with labs in Beijing, Taicang, the UK and North Carolina. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital